🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Eugene Braunwald

Brigham and Women's Hospital

ORCID: 0000-0002-3472-626X

Also affiliated with Harvard University, Thrombolysis in Myocardial Infarction Study Group, Mass General Brigham

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 4%percentile
0.826Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Efficacy and Safety of Non–Vitamin-K Antagonist Oral Anticoagulants Versus Warfarin Across the Spectrum of Body Mass Index and Body Weight: An Individual Patient Data Meta-Analysis of 4 Randomized Clinical Trials of Patients With Atrial Fibrillation

Circulation(2024)10.1161/circulationaha.123.066279
Top 24%
0.826DataRank
Top 24%27 citations

Eugene Braunwald, Jan Steffel, Giuseppe Boriani, Michael G. Palazzolo, Elliott M. Antman +12 more

Papers

Driven by 19 papers — median percentile 76. Top paper: “Valsartan in early-stage hypertrophic cardiomyopathy: a randomized phase 2 trial”.

Valsartan in early-stage hypertrophic cardiomyopathy: a randomized phase 2 trial

Nature Medicine(2021)10.1038/s41591-021-01505-4
N/A
3.8DataRank · unranked
134 citations

Sharlene M. Day, Anna Axelsson Raja, Mark W. Russell, Kenneth Zahka, Harry M. Lever +40 more

Tolerability of Sacubitril/Valsartan in Patients With Advanced Heart Failure

JACC Heart Failure(2022)10.1016/j.jchf.2022.04.013
N/A
1.3DataRank · unranked
34 citations

Michael M. Givertz, Randall C. Starling, Steven E. McNulty, Kevin J. Anstrom, Patrice Desvigne‐Nickens +4 more

The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels

New England Journal of Medicine(1996)10.1056/nejm199610033351401
N/A
1.3DataRank · unranked
7480 citations

Marc A. Pfeffer, Lemuel A. Moye, Jean L. Rouleau, John D. Rutherford, Thomas G. Cole +10 more

Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes

New England Journal of Medicine(2007)10.1056/nejmoa0706482
N/A
1.3DataRank · unranked
6726 citations

Eugene Braunwald, Carolyn H. McCabe, Gilles Montalescot, Witold Ruzyllo, Shmuel Gottlieb +12 more

Prognostic Importance of NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) Following High-Risk Myocardial Infarction in the PARADISE-MI Trial

Circulation Heart Failure(2023)10.1161/circheartfailure.122.010259
N/A
1.3DataRank · unranked
52 citations

Brian Claggett, Marc A. Pfeffer, Christopher B. Granger, Lars Køber, Eldrin F. Lewis +10 more

Efficacy and Safety of Non–Vitamin-K Antagonist Oral Anticoagulants Versus Warfarin Across the Spectrum of Body Mass Index and Body Weight: An Individual Patient Data Meta-Analysis of 4 Randomized Clinical Trials of Patients With Atrial Fibrillation

Circulation(2024)10.1161/circulationaha.123.066279
Top 24%
0.826DataRank
Top 24%27 citations

Eugene Braunwald, Jan Steffel, Giuseppe Boriani, Michael G. Palazzolo, Elliott M. Antman +12 more

Meta-analysis of genome-wide associations and polygenic risk prediction for atrial fibrillation in more than 180,000 cases

Nature Genetics(2025)10.1038/s41588-024-02072-3
N/A
0.821DataRank · unranked
50 citations

Ida Surakka, Morten S. Olesen, Garðar Sveinbjörnsson, Nicholas Marston, Seung Hoan Choi +95 more

Risk Assessment of Kidney Disease Progression and Efficacy of SGLT2 Inhibition in Patients With Type 2 Diabetes

Diabetes Care(2023)10.2337/dc23-0492
N/A
0DataRank · unranked
14 citations

David D. Berg, Andrea Bellavia, Jamie P. Dwyer, Ofri Mosenzon, Benjamin M. Scirica +8 more

Natriuretic Peptides, Body Mass Index and Heart Failure Risk: Pooled Analyses of SAVOR-TIMI 53, DECLARE-TIMI 58 and CAMELLIA-TIMI 61

European Journal of Heart Failure(2023)10.1002/ejhf.3118
N/A
0DataRank · unranked
9 citations

David A. Morrow, Andrea Bellavia, David D. Berg, Deepak L. Bhatt, Petr Jarolı́m +11 more

Risk and benefits of baseline antiplatelet therapy in 58,598 patients with atrial fibrillation randomized to NOACs vs warfarin

European Heart Journal(2023)10.1093/eurheartj/ehad655.2849
N/A
0DataRank · unranked
1 citations

Michael G. Palazzolo, Elliott M. Antman, Eugene Braunwald, Anthony Carnicelli, Stuart J. Connolly +6 more

Effects of statin therapy on diagnoses of new-onset diabetes and worsening glycaemia in large-scale randomised blinded statin trials: an individual participant data meta-analysis

The Lancet Diabetes & Endocrinology(2024)10.1016/s2213-8587(24)00040-8
N/A
0DataRank · unranked
143 citations

David Preiss, Lisa Blackwell, Jonathan Emberson, Enti Spata, Kelly Davies +95 more

Clonal hematopoiesis, cardiovascular events and treatment benefit in 63,700 individuals from five TIMI randomized trials

Nature Medicine(2024)10.1038/s41591-024-03188-z
N/A
0DataRank · unranked
42 citations

James P. Pirruccello, Giorgio Melloni, Frederick Kamanu, Marc P. Bonaca, Robert P. Giugliano +12 more

A Polygenic Risk Score to Predict Incident Heart Failure Across the Spectrum of Cardiovascular Risk

Journal of the American College of Cardiology(2025)10.1016/j.jacc.2025.06.050
N/A
0DataRank · unranked
5 citations

Giorgio Melloni, David D. Berg, Frederick Kamanu, Yi-Pin Lai, Elliott M. Antman +17 more

Prospective ARNI vs. ACE inhibitor trial to DetermIne Superiority in reducing heart failure Events after Myocardial Infarction (PARADISE‐MI): design and baseline characteristics

European Journal of Heart Failure(2021)10.1002/ejhf.2191
N/A
0DataRank · unranked
109 citations

Brian Claggett, Marc A. Pfeffer, Christopher B. Granger, Lars Køber, Eldrin F. Lewis +20 more

Serial assessment of biomarkers and the risk of stroke or systemic embolism and bleeding in patients with atrial fibrillation in the ENGAGE AF-TIMI 48 trial

European Heart Journal(2021)10.1093/eurheartj/ehab141
N/A
0DataRank · unranked
41 citations

Robert P. Giugliano, David D. Berg, Christian T. Ruff, Petr Jarolı́m, Minao Tang +7 more

Genetic Risk Score to Identify Risk of Venous Thromboembolism in Patients With Cardiometabolic Disease

Circulation Genomic and Precision Medicine(2021)10.1161/circgen.120.003006
N/A
0DataRank · unranked
14 citations

Giorgio Melloni, Yared Gurmu, Marc P. Bonaca, Frederick Kamanu, Carolina Roselli +17 more

A polygenic risk score predicts atrial fibrillation in cardiovascular disease

European Heart Journal(2022)10.1093/eurheartj/ehac460
N/A
0DataRank · unranked
82 citations

Amanda C. Garfinkel, Frederick Kamanu, Giorgio Melloni, Carolina Roselli, Petr Jarolı́m +15 more

Sixty-Year Evolution of Surgical Myectomy for Symptomatic Obstructive Hypertrophic Cardiomyopathy with Insights From the Historic NIH Surgical Experience to Present

The American Journal of Cardiology(2022)10.1016/j.amjcard.2022.02.035
N/A
0DataRank · unranked
5 citations

Douglas R. Rosing, Eugene Braunwald, Hassan Rastegar, Benjamin Koethe, William C. Roberts +3 more

Leaders in cardiovascular research: Eugene Braunwald

Cardiovascular Research(2022)10.1093/cvr/cvac033
N/A
0DataRank · unranked
1 citations

Tomasz J Guzik, Eugene Braunwald